Leslie Meltzer - Chief Research and Development at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Research and Development
Stock Symbol
APLS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Leslie Meltzer since 10/10/2024

Holdings reported by Leslie Meltzer for Apellis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 61.8K $1.73M $27.93 Aug 26, 2025 Direct
Stock Option (Right to Buy) 92.6K Aug 26, 2025 Direct Common Stock

Transactions reported by Leslie Meltzer for Apellis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.